| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2017-07-17 |
复牌提示：
2017-07-17 08:13:49 停牌，复牌日期 2017-07-18 00:00:01
|
| 2017-04-10 |
股东大会：
将于2017-06-15召开股东大会
会议内容 ▼▲
- 1.To approve the merger of the Company with Rendel Amare Ltd. (“Merger Sub”), a company formed under the laws of the State of Israel and a wholly-owned subsidiary of Lupert Ltd., a company formed under the laws of the State of Israel (“Parent”), including the approval of: (i) the merger transaction pursuant to Sections 314 through 327 of the Israel Companies Law, whereby Merger Sub will merge with and into the Company, with the Company surviving and becoming a wholly-owned subsidiary of Parent (the “Merger”); (ii) the Agreement and Plan of Merger, dated as of April 2, 2017, by and among Parent, Merger Sub and the Company (the “Merger Agreement”); (iii) the consideration to be received by the Company’s shareholders in the Merger, consisting of US $11.00 in cash (the “Merger Consideration”), without interest and subject to applicable withholding taxes, for each ordinary share held as of immediately prior to the effective time of the Merger; (iv) the conversion of each outstanding option that is unexercised immediately prior to the effective time of the Merger, whether vested or unvested, to purchase one ordinary share, including options held by Company directors, into the right to receive an amount of cash equal to the excess, if any, of the Merger Consideration over the applicable exercise price of such option, without interest and subject to any withholding obligations; (v) the conversion of each outstanding restricted share unit (“RSU”) that is unsettled immediately prior to the effective time of the Merger, whether vested or unvested, representing the right to receive one ordinary share, including RSUs held by Company directors, into the right to receive an amount of cash equal to the excess, if any, of the Merger Consideration over the applicable purchase price per ordinary share of such RSU, without interest and subject to any withholding obligations; and (vi) all other transactions and arrangements contemplated by the Merger Agreement, including directors’ and officers’ liability insurance (all of the above referred to as the “Merger Proposal”).
|
| 2017-03-23 |
详情>>
股本变动：
变动后总股本3501.84万股
|
| 2017-03-23 |
详情>>
业绩披露：
2016年年报每股收益0.01美元,归母净利润17.90万美元,同比去年增长102.82%
|
| 2016-07-20 |
股东大会：
将于2016-09-12召开股东大会
会议内容 ▼▲
- 1. Approve and ratify the re-appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the Company's independent auditors for the 2016 fiscal year and for an additional period until the next Annual General Meeting;
2. Re-elect Mr. Stephen J. Fanning and Ms. Yaffa Krindel, whose current terms as directors expire at the Meeting, as Class II directors to hold office until the end of the third Annual General Meeting of Shareholders of the Company to be held after the Meeting or until their successors have been duly elected;
3. Re-elect Dr. Michael Anghel and Mr. Dan Suesskind as the Company’s external directors for three-year terms, effective as of November 7, 2016, in accordance with the provisions of the Israel Companies Law;
4. Approve an updated compensation policy regarding the terms of service and employment of the directors and officers of the Company, in accordance with the provisions of the Israel Companies Law;
5. Approve such other business as may properly come before the Annual General Meeting or any or all adjournments or postponements thereof.
|
| 2016-03-21 |
详情>>
业绩披露：
2015年年报每股收益-0.17美元,归母净利润-634万美元,同比去年增长-21.92%
|
| 2015-05-14 |
股东大会：
将于2015-06-24召开股东大会
会议内容 ▼▲
- 1.Approve and ratify the re-appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the Company's independent auditors for the 2015 fiscal year and for an additional period until the next Annual General Meeting;
2.Re-elect Mr. David Schlachet and Mr. Dominick Arena, whose current terms as directors expire at the Meeting, as Class I directors to hold office until the end of the third Annual General Meeting of Shareholders of the Company to be held after the Meeting or until their successors have been duly elected;
3.Approve compensation of Dr. Shimon Eckhouse as Active Chairman of the Board of Directors of the Company;
4.Approve such other business as may properly come before the Annual General Meeting or any or all adjournments or postponements thereof.
|
| 2015-03-24 |
详情>>
业绩披露：
2014年年报每股收益-0.14美元,归母净利润-520万美元,同比去年增长-415.73%
|
| 2014-06-02 |
股东大会：
将于2014-07-15召开股东大会
会议内容 ▼▲
- 1. Approve and ratify the re-appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the Company's independent auditors for the 2014 fiscal year and for an additional period until the next Annual General Meeting;
2. Re-elect Mr. Shimon Eckhouse, whose current term as director expires at the Meeting, as a Class III director to hold office until the end of the third Annual General Meeting of Shareholders of the Company to be held after the Meeting or until his successor has been duly elected;
3. Approve the 2014 Israeli Stock Incentive Plan;
4. Approve the 2014 U.S. Stock Incentive Plan;
5. Approve such other business as may properly come before the Annual General Meeting or any or all adjournments or postponements thereof.
|
| 2014-03-19 |
详情>>
业绩披露：
2013年年报每股收益0.04美元,归母净利润164.70万美元,同比去年增长222.64%
|
| 2013-06-17 |
股东大会：
将于2013-07-18召开股东大会
会议内容 ▼▲
- 1. Approve and ratify the re-appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the Company's independent auditors for the 2013 fiscal year and for an additional period until the next Annual General Meeting;
2. Re-elect Ms. Yaffa Krindel, whose current term as director expires at the Meeting, as a Class II director to hold office until the end of the third Annual General Meeting of Shareholders of the Company to be held after the Meeting or until her successor has been duly elected;
3. Re-elect Dr. Michael Anghel and Mr. Dan Suesskind as the Company’s external directors for three-year terms, effective as of November 7, 2013, in accordance with the provisions of the Israeli Companies Law;
4. Approve a compensation policy regarding the terms of service and employment of the directors and officers of the Company, in accordance with the provisions of the Israeli Companies Law, including compensation to the Chief Executive Officer;
5. Approve compensation to Mr. David Schlachet for his service as Chairman of the Board of Directors;
6. Approve compensation to Mr. David Schlachet for his prior service as interim Chief Financial Officer from August to November 2012;
7. Approve updated compensation to directors of the Company;
8. Approve a grant of options to acquire shares of Syneron Beauty Ltd., a wholly-owned subsidiary of the Company, to each of Mr. David Schlachet and Dr. Michael Anghel, both of whom serve on the board of directors of the Company and of Syneron Beauty Ltd.
9. Approve such other business as may properly come before the Annual General Meeting or any or all adjournments or postponements thereof.
|
| 2013-03-21 |
详情>>
业绩披露：
2012年年报每股收益-0.04美元,归母净利润-134.3万美元,同比去年增长97.36%
|
| 2012-03-29 |
详情>>
业绩披露：
2011年年报每股收益-1.44美元,归母净利润-5079.5万美元,同比去年增长-98.92%
|
| 2011-03-28 |
详情>>
业绩披露：
2010年年报每股收益-0.74美元,归母净利润-2553.6万美元,同比去年增长-8.26%
|